Coffee and Health

caffiene.gif (28885 bytes)


Caffeine/Caffeine and heart disease / Caffeine and woman

 

[Home] [History] [Bean] [Brewing Method] [Espresso][Recipes] [Roasting] [Glossary]

 

Caffeine                                            

 The amount of caffeine in a cup of coffee can vary greatly, depending on its origin or the composition of the blend, the method of brewing and the strength of the brew. Instant, or soluble, coffee generally contains less caffeine than roast and ground coffee, but may be consumed in greater volume. Robusta coffees have about twice as much caffeine as arabicas. A 'cup' is usually understood to contain 150 ml (5 oz in the United States) but an espresso may be as small as 40 ml.

The U.S. Food and Drug Administration gives the following ranges for caffeine contents:

(mg per 5 oz cup)

 

 

  range average
Roast and ground    
-drip method 60-180 115
-percolator 40-170 80
     
Instant coffee 30-120 65

 

LEVELS OF CAFFEINE CONSUMPTION

Caffeine is generally consumed in amounts less than 300mg per day, roughly equivalent to:

3-4 cups of roast and ground coffee

5 cups of instant coffee

5 cups of tea

6 servings of some colas or

10 tablets of some Painkillers

 It has been suggested that the British consume more caffeine on average than Americans, but there are no large scale studies to support the observation. The nine, normal subjects recruited by Dr M.S. Bruce and his colleagues, as habitual caffeine users, for a study in London (reference below) were found to consume on average 428mg caffeine a day, with a range from 230mg to 670mg.

Customary caffeine consumption has been classified as follows:

Low caffeine users: less than 200mg per day

Moderate caffeine users: 200-400mg per day

High caffeine users: more than 400mg per day

 

Caffeine and Heart Disease

 
Studies On CAFFEINE AND CARDIOVASCULAR DISEASE
New Evidence

Warren G. Thompson, M.D., noted in a 1994 literature review on this subject: "The largest and better studies suggest that coffee is not a major risk factor for coronary disease." (1)

Willet et. al, in a prospective study reported in the February 1996 issue of the Journal of the American Medical Association (JAMA), examined data collected from more than 85,000 women over a 10-year period. After adjusting for known risk factors, the authors found no evidence for any positive association between coffee consumption and risk of CVD for women consuming six or more cups of coffee a day. (2)

A 1990 study of more than 45,000 men found no link between coffee, caffeine and CVD for those drinking four or more cups of coffee a day. (3)

These results confirm findings from the earlier Framingham Heart Study of more than 6,000 adults conducted over 20 years (4) and two 1987 studies using data from the Honolulu Heart Program. (5-6)

Blood Pressure

Studies indicate that while first-time caffeine use may produce immediate, minimal changes in blood pressure, these changes are transient. (7) No changes in blood pressure appear to occur in regular users of caffeine. A 1991 study reached the same conclusion and indicated that restricting caffeine did not reduce blood pressure in people with mild hypertension. (8) A number of studies that have looked at people with normal blood pressure have concluded that caffeine does not contribute to hypertension. (4,9,10)

In 1997, the Sixth Report of the National Institutes of Health's Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure concluded that, "no direct relationship between caffeine intake and elevated blood pressure has been found in most epidemiologic surveys (12)."

Heart Arrhythmias

In a 1991 article reviewing virtually all research on coffee, caffeine and arrhythmias, Martin G. Meyers, M.D., concluded that the ingestion of 500 mg of caffeine, the equivalent of five to six 8-ounce cups of coffee a day, does not increase the frequency or severity of cardiac arrhythmias or ventricular tachycardia (increased heart rate) in healthy people or those with CVD. (11)

 

CAFFEINE AND WOMEN'S HEALTH

 

 

Defining Caffeine Consumption

Studies on caffeine and various health effects tend to look at moderate? versus heavy? caffeine consumption. While there are no consistent definitions of consumption levels, moderate? is typically defined as up to 300-400 milligrams (mg) a day -- the equivalent of 3-5, 8 oz. cups. More than this is usually considered heavy? consumption.

While there continue to be areas of debate, the weight of scientific evidence indicates that coffee and caffeine as consumed in the American diet are safe and do not effect fertility or cause adverse health effects in the mother or fetus.

Birth Defects

A 1980 FDA study, in which researchers fed rodents large amounts of caffeine via stomach tubes, prompted an advisory for pregnant women to avoid caffeine. However, as a result of a significant amount of criticism regarding how the study was conducted, a second study was undertaken. The follow-up study, in which rodents consumed high levels of caffeine in their drinking water, found no effect.

This second study allayed the concerns that were generated by the initial 1980 study. This was reflected by Leviton in his 1995 review, who noted that only two studies since 1986 have evaluated the relationship between coffee/caffeine consumption and birth defects. These studies, by Olsen and McDonald, show no significant increased risk of malformation in babies born to mothers who consumed the most coffee (eight cups or more). (10, 11)

The FDA continues to advise pregnant women to consume caffeine in moderation as ought to be practiced with other dietary habits.

Prematurity

While a 1992 study identified a slight? increased risk with coffee consumption (32), a 1995 study by Pastore and Savitz concluded [our] results do not support an association between caffeinated beverage consumption and pre-term delivery, as is true in most previous studies.? (13)

Birth Weight

A 1993 study by Larroque, et. al., showed no association between the highest level of caffeine intake (more than 800 mg) and low birth weight once researchers controlled for factors including maternal age, smoking and alcohol consumption. (8) Additionally, a prospective 1995 study by Shu, et. al, concluded caffeine consumption showed no relation to fetal growth, even among heavy consumers? (up to 800 mg/day), after controlling for alcohol and smoking. (9). These findings are in contrast to those of the 1991 study by Fenster, et. al., which linked heavy caffeine consumption (more than 300 mg/day) with increased risk for intrauterine growth retardation and low birth weight (33).

Decreased Fertility

The authors of a 1995 paper (Alderete, et. al.) on caffeine intake and time to conception concluded we found no decrease in fertility among coffee consumers even at more than three cups per day.? These findings refute those of an earlier study, Wilcox et. al, which suggested an association between decreased fertility and 100 mg or more of caffeine per day (34). The researchers acknowledged that the decrease could be attributable to confounding factors, such as exercise, stress and nutrition, which the study did not address. Confounding factors also were problematic in a 1993 study by Hatch and Bracken, which concluded that consuming increasing amounts of caffeine is related to increasing delays in time to conception. A commentary on this study confirmed the researchers' own concerns, however, that women who conceive quickly may reduce caffeine consumption even before they are aware they are pregnant because of a natural aversion to caffeine that occurs during pregnancy,? thereby creating the potential for bias (35).

Fibrocystic Breast Disease (FBD)

In the late 1970s surgeon John Minton completed research suggesting a possible link between FBD and consumption of methylxanthines, a group of purine-based compounds that includes caffeine (36). However, a 1986 study of more than 3,400 women conducted at the National Cancer Institute found no relationship between FBD and caffeine intake (16). That same year, a review of nine major studies reported there is little evidence to support the association between methylxanthine consumption and fibrocystic breast disease.? (17)

Some physicians have suggested that women with FBD may be particularly caffeine-sensitive. (37) However, an extensive literature review by Wolfrom and Welsch in 1990 concluded that reducing or eliminating methylxanthine consumption has no consistent beneficial effect on FBD symptoms. (36) A February 1995 commentary states that by and large, today's doctors feel that stopping caffeine is not really necessary? to reduce or prevent symptoms of FBD. (38) However, if a patient feels that caffeine makes her breasts more tender at certain times of the month, she should limit caffeine consumption to a level she is comfortable with.

Breast Cancer

At the time Minton completed his research on FBD, some researchers believed that the incidence of breast cancer was higher in women with FBD. They assumed, therefore, that caffeine consumption could lead to increased incidence of breast cancer (39,40). In 1992, Graham, et. al. concluded that contrary to the suggestion of Minton, we found no [breast cancer] risk associated with drinking coffee or any other caffeine-containing beverage. To our knowledge, no large-scale epidemiological study has ever done so.? (20)

Osteoporosis

A 1997 study by Lloyd, et. al., found no association between lifetime caffeine consumption and bone changes or osteoporosis risk in postmenopausal women (31). The researchers studied women who were low, moderate and high caffeine consumers, and controlled for exercise habits and hormone replacement therapy use.

In a 1996 longitudinal study of 145 healthy, college-aged women (20-30 years old), researchers concluded that moderate caffeine intake (defined in this study as one cup of coffee per day) was not associated with significant reduction in rates of bone gain in women in the third decade of life (41). This was one of the first studies to examine the effects of caffeine on bone mass in young women, 30 years of age or younger, who continue to gain bone.

Several studies completed between 1990 and 1995 have identified a net loss of urinary calcium or bone in subjects with high caffeine intake (42-44); however, it is difficult to extrapolate the results of these studies to the general population because the studies did not carefully control for confounding factors and/or included subjects with exceptionally high caffeine intake.

Other recent studies have found either that moderate caffeine consumption has no effect on total bone density or that any potential effects can be prevented by consuming adequate calcium. (26)

A 1994 study by Barrett-Connor, et. al., found a significant association between caffeine consumption and decreased bone density only among women who did not drink at least one glass of milk per day during most of their adult lives. (22)

A 1995 analysis by Barger-Lux and Heaney concluded that one glass of milk provides enough calcium to offset the negative effect of eight cups of caffeine-containing coffee...this equivalence highlights the fact that it is not so much that caffeine is a risk factor for osteoporosis; rather, it is inadequate intake of calcium which is the principal culprit and which allows other minor players, such as caffeine, to express their effects.? (29)


[Home] [History] [Bean] [Brewing Method] [Espresso][Recipes] [Roasting] [Glossary]